Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

4.57
Delayed Data
As of Mar 24
 +0.10 / +2.24%
Today’s Change
2.54
Today|||52-Week Range
7.15
-24.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization38.0K41.0K114.0K40.0K
 
 
 
 
 
 
Operating ExpensesGross Income-38.0K-41.0K-114.0K-40.0K
 
 
 
 
 
General Expenses27.5M36.8M38.4M42.4M
 
 
 
 
 
Research And Development21.2M26.6M24.6M17.2M
 
 
 
 
 
Total Operating Expenses27.6M36.9M38.5M42.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.6M-36.9M-38.5M-42.4M
 
 
 
 
 
Extraordinary Credit260.0K0.000.000.00
 
 
Extraordinary Charge-25.6M-23.0K-87.0K-14.6M
 
 
 
 
 
Interest Expense On Debt7.0M1.7M1.7M3.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-59.9M-38.6M-40.2M-60.0M
 
 
 
 
 
Income Taxes0.000.000.00-126.0K
 
 
Net Income-59.9M-38.6M-40.2M-59.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS117.6M168.1M179.8M190.1M
 
 
 
 
 
Shares To Calculate EPS Diluted117.6M168.1M179.8M190.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.23-$0.22-$0.31
 
 
 
 
 
EPS Diluted-$0.51-$0.23-$0.22-$0.31